RETRACTED: Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke

Yoshihiro Sato, Jun Iwamoto, Tomohiro Kanoko, Kei Satoh

Open source

DOI
10.1001/archinte.165.15.1743
Published
2005-08-08
Container
Archives of Internal Medicine
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/archinte.165.15.1743,
  title = {RETRACTED: Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke},
  author = {Yoshihiro Sato and Jun Iwamoto and Tomohiro Kanoko and Kei Satoh},
  year = {2005},
  journal = {Archives of Internal Medicine},
  doi = {10.1001/archinte.165.15.1743},
  url = {https://doi.org/10.1001/archinte.165.15.1743}
}

RIS

TY  - JOUR
TI  - RETRACTED: Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke
AU  - Yoshihiro Sato
AU  - Jun Iwamoto
AU  - Tomohiro Kanoko
AU  - Kei Satoh
PY  - 2005
JO  - Archives of Internal Medicine
DO  - 10.1001/archinte.165.15.1743
UR  - https://doi.org/10.1001/archinte.165.15.1743
ER  - 

APA

Sato, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005). RETRACTED: Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke. Archives of Internal Medicine. https://doi.org/10.1001/archinte.165.15.1743

Source records